| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/13/2015 | US8932828 Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins |
| 01/13/2015 | US8932827 Process and system for obtaining botulinum neurotoxin |
| 01/13/2015 | US8932825 Method to engineer mammalian-type carbohydrate structures |
| 01/13/2015 | US8932821 NOGO receptor binding protein |
| 01/13/2015 | US8932806 Method for identifying t-cell stimulating protein fragments |
| 01/13/2015 | US8932651 Functional food product comprising heat shock protein or a hydrolysate thereof |
| 01/13/2015 | US8932601 Hybrid and chimeric polypeptides that regulate activation of complement |
| 01/13/2015 | US8932600 Modified tuberculosis antigens |
| 01/13/2015 | US8932599 Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines |
| 01/13/2015 | US8932598 Fusion proteins and methods of use |
| 01/13/2015 | US8932593 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 01/13/2015 | US8932591 Formulation of human antibodies for treating TNF-α associated disorders |
| 01/13/2015 | US8932589 Methods and compositions using Kloto-FGF23 fusion polypeptides |
| 01/13/2015 | US8932586 Modified forms of Pseudomonas exotoxin A |
| 01/13/2015 | US8932580 Methods for purification of bacterial cells and cell components |
| 01/13/2015 | US8932574 Stable liquid interferon beta formulations |
| 01/13/2015 | CA2612151C Agents and methods based on the use of the eda domain of fibronectin |
| 01/13/2015 | CA2602028C Method for isolation of soluble polypeptides |
| 01/13/2015 | CA2591297C Il-7 variants with reduced immunogenicity |
| 01/13/2015 | CA2580426C Deglycosylated and desialidated long pentraxin ptx3 |
| 01/13/2015 | CA2489410C Molecular antigen arrays |
| 01/08/2015 | WO2015002985A2 Fc coupled compositions and methods of their use |
| 01/08/2015 | WO2015002959A1 Vaccine comprising ama1 and ron2 |
| 01/08/2015 | WO2015002611A1 Compositions and methods for inhibiting thrombogenesis |
| 01/08/2015 | WO2015001526A1 Immunogenic peptides of the cyclin b1 tumour antigen |
| 01/08/2015 | WO2015001521A1 Method for inducing targeted meiotic recombination |
| 01/08/2015 | WO2015001467A1 Increased meiotic recombination in plants by inhibition of the fidg protein |
| 01/08/2015 | WO2015001361A1 Immunotherapy |
| 01/08/2015 | WO2015001187A1 Concentration and purification of hydrophobins and antibodies with a phase separation method |
| 01/08/2015 | WO2015001082A1 Novel alternative splice transcripts for mhc class i related chain alpha (mica) and uses thereof |
| 01/08/2015 | WO2015001049A1 O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof |
| 01/08/2015 | WO2015001045A2 Pro-apoptotic ras and raf peptides |
| 01/08/2015 | WO2015000942A1 Derivatives of glp-1 like peptides, and uses thereof |
| 01/08/2015 | WO2015000914A1 Methods and means for modulating flowering time in monocot plants |
| 01/08/2015 | WO2015000413A1 Long-acting blood sugar decreasing fusion protein |
| 01/08/2015 | WO2015000181A1 Novel recombinant fusion protein, preparation method therefor and use thereof |
| 01/08/2015 | WO2015000014A1 Diagnosis and treatment of autoimmune diseases |
| 01/08/2015 | US20150013032 Use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 01/08/2015 | US20150013030 Plant transcriptional regulators |
| 01/08/2015 | US20150013023 Humanized il-6 and il-6 receptor |
| 01/08/2015 | US20150013022 Humanized il-6 and il-6 receptor |
| 01/08/2015 | US20150011734 Protein and gene related with basal thermotolerance of plants |
| 01/08/2015 | US20150011733 Collagen 7 and related methods |
| 01/08/2015 | US20150011732 Polymer conjugates of interferon beta-1a and uses |
| 01/08/2015 | US20150011729 Nucleotide repeat expansion-associated polypeptides and uses thereof |
| 01/08/2015 | US20150011482 Nutritive Fragments, Proteins and Methods |
| 01/08/2015 | US20150011476 Modified collagen |
| 01/08/2015 | US20150011474 Polypeptides binding to human complement c5 |
| 01/08/2015 | US20150011469 Method of treating diabetes using non-glycosylated apolipoprotein a-iv |
| 01/08/2015 | US20150011467 Oxyntomodulin analogues and their effects on feeding behaviour |
| 01/08/2015 | US20150011464 Antibacterial polypeptides and use thereof |
| 01/08/2015 | US20150011459 Shortened tetranectin-apolipoprotein a-1 fusion protein, a lipid particle containing it, and uses thereof |
| 01/08/2015 | US20150011431 Humanized antibodies |
| 01/08/2015 | US20150011417 Membrane span-kinase fusion protein and the uses thereof |
| 01/08/2015 | US20150011017 Diagnosis and risk stratification by means of the novel marker ct-proadm |
| 01/08/2015 | US20150010982 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
| 01/08/2015 | US20150010948 Fermentation process |
| 01/08/2015 | US20150010947 Domain Swapping Modules |
| 01/08/2015 | US20150010946 Polynucleotides encoding zcytor17 ligand antibodies |
| 01/08/2015 | US20150010945 Methods and systems for tracking bioremediation processes |
| 01/08/2015 | US20150010944 Modified sak gene for the production of recombinant proteins |
| 01/08/2015 | US20150010925 Co-translational activation of a transcription factor by porteolytic cleavage and methods of use |
| 01/08/2015 | US20150010915 CRYSTAL STRUCTURE OF THE NanR AND ManNAc-6P COMPLEX, AND USES THEREOF |
| 01/08/2015 | US20150010597 Compositions and methods for vaccinating against hsv-2 |
| 01/08/2015 | US20150010595 Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule |
| 01/08/2015 | US20150010590 Immunogenic pote peptides and methods of use |
| 01/08/2015 | US20150010589 Aegyptin and uses thereof |
| 01/08/2015 | US20150010587 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 01/08/2015 | US20150010586 p53 Peptide Vaccine |
| 01/08/2015 | US20150010584 Targeted Delivery Of Autoantigens To B Cell Populations |
| 01/08/2015 | US20150010579 Treatment and Prevention of Gardnerella Vaginalis Infections |
| 01/08/2015 | US20150010576 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/08/2015 | US20150010570 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 01/08/2015 | US20150010557 Propylene Glycol Compositions for Intranasal Administration of Active Agents to the Central Nervous System |
| 01/08/2015 | US20150010555 Compositions and methods for increasing serum half-life |
| 01/08/2015 | US20150010551 Compositions and Methods of Treating Tumors |
| 01/08/2015 | US20150010535 Methods of Identifying a Compound that Increases or Decreases the Interaction of Hn-33 with Synaptotagmin II |
| 01/08/2015 | US20150010495 Method for the production of an immunostimulating mucin (muc1) |
| 01/07/2015 | EP2821505A2 Nucleotide-specific recognition sequences for designer tal effectors |
| 01/07/2015 | EP2821493A1 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 01/07/2015 | EP2821486A1 Method of introducing nucleic acid into plant cells |
| 01/07/2015 | EP2821414A1 Kappa casein fragments inhibiting gingipains |
| 01/07/2015 | EP2821413A1 Nucleotide-specific recognition sequences for designer tal effectors |
| 01/07/2015 | EP2820127A1 Targeted histone acetylation |
| 01/07/2015 | EP2820041A1 Iaspp phosphorylation and metastatic potential |
| 01/07/2015 | EP2820040A1 Method for reduction of 1->2 reading frame shifts |
| 01/07/2015 | EP2820039A1 Method for reduction of 1->3 reading frame shifts |
| 01/07/2015 | EP2820038A1 Glp-1 prodrugs |
| 01/07/2015 | EP2820037A1 Modulation of seed vigor |
| 01/07/2015 | EP2820036A1 Replacement therapy for dental caries |
| 01/07/2015 | EP2820035A1 Method of altering the immundominance hierarchy of hiv gag by dna vaccine expressing conserved regions |
| 01/07/2015 | EP2820034A1 Modified adiponectin polypeptides and their uses |
| 01/07/2015 | EP2820033A1 Interleukin-10 polypeptide conjugates and their uses |
| 01/07/2015 | EP2820032A1 Truncated lysosomal acid lipase |
| 01/07/2015 | EP2820031A1 On-column enzymatic cleavage |
| 01/07/2015 | CN104271748A 表达异源肿瘤相关抗原的腺病毒 Heterologous expression of tumor-associated antigens adenovirus |
| 01/07/2015 | CN104271745A 用于治疗巨细胞病毒的组合物和方法 Treatment of cytomegalovirus compositions and methods for |
| 01/07/2015 | CN104271744A 分枝杆菌感染的预防和治疗 Mycobacterial infection prevention and treatment |
| 01/07/2015 | CN104271732A 用于减弱结核分枝杆菌复合群的细菌以生产结核病疫苗的方法 For attenuating the bacteria Mycobacterium tuberculosis complex of a method to produce TB vaccine |
| 01/07/2015 | CN104271596A 肽激素的降钙素cgrp家族的肽拮抗剂和它们的用途 Peptide hormone calcitonin family of peptides cgrp antagonists and their uses |